135 related articles for article (PubMed ID: 34662125)
41. Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials.
Matralis AN; Afantitis A; Aidinis V
Med Res Rev; 2019 May; 39(3):976-1013. PubMed ID: 30462853
[TBL] [Abstract][Full Text] [Related]
42. Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging.
Van Laere K; Ahmad RU; Hudyana H; Celen S; Dubois K; Schmidt ME; Bormans G; Koole M
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):254-61. PubMed ID: 23160998
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate.
Li J; Zhang X; Jin H; Fan J; Flores H; Perlmutter JS; Tu Z
J Med Chem; 2015 Nov; 58(21):8584-600. PubMed ID: 26430878
[TBL] [Abstract][Full Text] [Related]
44. Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.
Bao X; Lu S; Liow JS; Zoghbi SS; Jenko KJ; Clark DT; Gladding RL; Innis RB; Pike VW
J Med Chem; 2012 Mar; 55(5):2406-15. PubMed ID: 22313227
[TBL] [Abstract][Full Text] [Related]
45.
Lee BS; Chu SY; Jung WJ; Jeong HJ; Lee K; Kim MH; Kim MH; Chi DY; Ahn H; Lee YJ; Lee KC; Lim SM
Prostate; 2020 Dec; 80(16):1383-1393. PubMed ID: 32960990
[TBL] [Abstract][Full Text] [Related]
46. Fluorinated CRA13 analogues: Synthesis, in vitro evaluation, radiosynthesis, in silico and in vivo PET study.
Hassan AHE; Park KT; Kim HJ; Lee HJ; Kwon YH; Hwang JY; Jang CG; Chung JH; Park KD; Lee SJ; Oh SJ; Lee YS
Bioorg Chem; 2020 Jun; 99():103834. PubMed ID: 32334193
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography.
Prasad VP; Wagner S; Keul P; Hermann S; Levkau B; Schäfers M; Haufe G
Bioorg Med Chem; 2014 Oct; 22(19):5168-81. PubMed ID: 25216968
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX).
East JE; Kennedy AJ; Tomsig JL; De Leon AR; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2010 Dec; 20(23):7132-6. PubMed ID: 20951039
[TBL] [Abstract][Full Text] [Related]
49. Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.
Nikolaou A; Ninou I; Kokotou MG; Kaffe E; Afantitis A; Aidinis V; Kokotos G
J Med Chem; 2018 Apr; 61(8):3697-3711. PubMed ID: 29620892
[TBL] [Abstract][Full Text] [Related]
50. A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity.
Kang TS; Wang W; Zhong HJ; Liang JX; Ko CN; Lu JJ; Chen XP; Ma DL; Leung CH
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):256-263. PubMed ID: 27888146
[TBL] [Abstract][Full Text] [Related]
51. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors.
Vrontaki E; Melagraki G; Kaffe E; Mavromoustakos T; Kokotos G; Aidinis V; Afantitis A
Curr Med Chem; 2016; 23(17):1708-24. PubMed ID: 26997151
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
[TBL] [Abstract][Full Text] [Related]
54. Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents.
Luo Z; Rosenberg AJ; Liu H; Han J; Tu Z
Eur J Med Chem; 2018 Apr; 150():796-808. PubMed ID: 29604582
[TBL] [Abstract][Full Text] [Related]
55. Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors.
Magkrioti C; Kaffe E; Stylianaki EA; Sidahmet C; Melagraki G; Afantitis A; Matralis AN; Aidinis V
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977539
[TBL] [Abstract][Full Text] [Related]
56. Development of [
Wong SW; Vivash L; Mudududdla R; Nguyen N; Hermans SJ; Shackleford DM; Field J; Xue L; Aprico A; Hancock NC; Haskali M; Stashko MA; Frye SV; Wang X; Binder MD; Ackermann U; Parker MW; Kilpatrick TJ; Baell JB
Eur J Med Chem; 2021 Dec; 226():113822. PubMed ID: 34563964
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and preliminary evaluation of
Lu X; Wang C; Li X; Gu P; Jia L; Zhang L
Bioorg Med Chem; 2019 Feb; 27(3):545-551. PubMed ID: 30611635
[TBL] [Abstract][Full Text] [Related]
58. PET Radioligands for imaging of the PDE10A in human: current status.
Boscutti G; A Rabiner E; Plisson C
Neurosci Lett; 2019 Jan; 691():11-17. PubMed ID: 30099081
[TBL] [Abstract][Full Text] [Related]
59. Radiofluorination of a NHC-PF
Vabre B; Chansaenpak K; Wang M; Wang H; Li Z; Gabbaï FP
Chem Commun (Camb); 2017 Aug; 53(62):8657-8659. PubMed ID: 28731482
[TBL] [Abstract][Full Text] [Related]
60. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
Patel S; Knight A; Krause S; Teceno T; Tresse C; Li S; Cai Z; Gouasmat A; Carroll VM; Barret O; Gottmukkala V; Zhang W; Xiang X; Morley T; Huang Y; Passchier J
Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
